siRNA‑mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin‑stimulated 
primary cultured microglia

Cheng,Hao; Wu,Zhifang; He,Xiaoyun; Liu,Qingzhen; Jia,Hongbin; Di,Yan; Ji,Qing

doi:10.3892/etm.2016.3575

siRNA‑mediated silencing of phosphodiesterase 4B expression affects the production of cytokines in endotoxin‑stimulated primary cultured microglia

Authors:
- Hao Cheng
- Zhifang Wu
- Xiaoyun He
- Qingzhen Liu
- Hongbin Jia
- Yan Di
- Qing Ji
View Affiliations

Affiliations: Department of Anesthesiology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu 210002, P.R. China
Published online on: August 4, 2016 https://doi.org/10.3892/etm.2016.3575
Pages: 2257-2264

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Phosphodiesterase 4 (PDE4) has four subtypes: PDE4A, PDE4B, PDE4C and PDE4D. The expression of PDE4 subtypes in microglial cells and the specific contribution of each subtype to inflammation remain unclear. In this study, the expression of PDE4 subtypes in primary microglial cells was assayed. Primary microglial cells were then transfected with specific small interfering RNA (siRNA) against each PDE4 subtype. PDE4 subtype A‑D knockdown was confirmed by quantitative polymerase chain reaction. Secreted cytokines in the supernatant and intracellular cyclic adenosine monophosphate (cAMP) levels of transfected cells were measured. The effect of PDE4B siRNA on the activation of extracellular regulated protein kinase (ERK) induced by lipopolysaccharide (LPS) in microglia was further tested by western blotting. Results showed that the primary microglial cells expressed all four types of PDE4s at the protein level. Transfection with the four siRNAs inhibited PDE4 subtype A‑D mRNA expression, respectively. In primary microglial cells, treatment with PDE4B siRNA significantly inhibited the expression of tumor necrosis factor‑α and interleukin (IL)‑1β, and enhanced the expression of cAMP, while siRNAs to other subtypes had no significant effects. However, none of the four siRNAs had any significant effect on the expression of IL‑10. Furthermore, in the PDE4B group, the level of phosphorylated ERK was reduced. Among the four PDE4 subtypes, PDE4B plays an important role in regulating inflammatory responses in microglia, potentially through initially regulating the intracellular cAMP concentration.

View Figures

View References

1	Gremo F, Sogos V, Ennas MG, Meloni A, Persichini T, Colasanti M and Lauro GM: Features and functions of human microglia cells. Adv Exp Med Biol. 429:79–97. 1997. View Article : Google Scholar : PubMed/NCBI
2	WyssCoray T and Rogers J: Inflammation in Alzheimer disease - a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med. 2:a0063462012.PubMed/NCBI
3	Karagkouni A, Alevizos M and Theoharides TC: Effect of stress on brain inflammation and multiple sclerosis. Autoimmun Rev. 12:947–953. 2013. View Article : Google Scholar : PubMed/NCBI
4	Campbell JN and Meyer RA: Mechanisms of neuropathic pain. Neuron. 52:77–92. 2006. View Article : Google Scholar : PubMed/NCBI
5	Aloisi F: Immune function of microglia. Glia. 36:165–179. 2001. View Article : Google Scholar : PubMed/NCBI
6	Garden GA and Möller T: Microglia biology in health and disease. J Neuroimmune Pharmacol. 1:127–137. 2006. View Article : Google Scholar : PubMed/NCBI
7	Buttini M, Mir A, Appel K, Wiederhold KH, Limonta S, Gebicke Haerter PJ and Boddeke HW: Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: Inhibition by methylprednisolone and by rolipram. Br J Pharmacol. 122:1483–1489. 1997. View Article : Google Scholar : PubMed/NCBI
8	Tanaka J, Toku K, Matsuda S, Sudo S, Fujita H, Sakanaka M and Maeda N: Induction of resting microglia in culture medium devoid of glycine and serine. Glia. 24:198–215. 1998. View Article : Google Scholar : PubMed/NCBI
9	Zhang B, Yang L, Konishi Y, Maeda N, Sakanaka M and Tanaka J: Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology. 42:262–269. 2002. View Article : Google Scholar : PubMed/NCBI
10	Conti M and Jin SL: The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol. 63:1–38. 1999. View Article : Google Scholar : PubMed/NCBI
11	Houslay MD: Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem Sci. 35:91–100. 2010. View Article : Google Scholar : PubMed/NCBI
12	Jarnagin K, Chanda S, Coronado D, Ciaravino V, Zane LT, GuttmanYassky E and Lebwohl MG: Crisaborole topical ointment, 2%: A nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis. J Drugs Dermatol. 15:390–396. 2016.PubMed/NCBI
13	Pearse DD and Hughes ZA: PDE4B as a microglia target to reduce neuroinflammation. Glia. Apr 1–2016.doi: 10.1002/glia.22986 (Epub ahead of print). View Article : Google Scholar
14	Flemming S, Schlegel N, Wunder C, Meir M, Baar W, Wollborn J, Roewer N, Germer CT and Schick MA: Phosphodiesterase 4 inhibition dose dependently stabilizes microvascular barrier functions and microcirculation in a rodent model of polymicrobial sepsis. Shock. 41:537–545. 2014. View Article : Google Scholar : PubMed/NCBI
15	Jin SL, Ding SL and Lin SC: Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Chang Gung Med J. 35:197–210. 2012.PubMed/NCBI
16	Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811. 1998. View Article : Google Scholar : PubMed/NCBI
17	Doré-Savard L, Roussy G, Dansereau MA, Collingwood MA, Lennox KA, Rose SD, Beaudet N, Behlke MA and Sarret P: Central delivery of Dicer-substrate siRNA: A direct application for pain research. Mol Ther. 16:1331–1339. 2008. View Article : Google Scholar : PubMed/NCBI
18	Röhl T and Kurreck J: RNA interference in pain research. J Neurochem. 99:371–380. 2006. View Article : Google Scholar : PubMed/NCBI
19	Jiang H, Bielekova B, Okazaki H, ClarenceSmith K, Johnson KP, Bergey G, Martin R and Dhib-Jalbut S: The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: A preclinical study for the treatment of multiple sclerosis. J Neuroimmunol. 97:134–145. 1999. View Article : Google Scholar : PubMed/NCBI
20	Xue Y, Wang Y, Feng DC, Xiao BG and Xu LY: Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-kappaB pathway. Acta Pharmacol Sin. 29:245–251. 2008. View Article : Google Scholar : PubMed/NCBI
21	Liu J, Zhao X, Cao J, Xue Q, Feng X, Liu X, Zhang F and Yu B: Differential roles of PKA and Epac on the production of cytokines in the endotoxin-stimulated primary cultured microglia. J Mol Neurosci. 45:186–193. 2011. View Article : Google Scholar : PubMed/NCBI
22	Choi DC, Lee JY, Lim EJ, Baik HH, Oh TH and Yune TY: Inhibition of ROS-induced p38MAPK and ERK activation in microglia by acupuncture relieves neuropathic pain after spinal cord injury in rats. Exp Neurol. 236:268–282. 2012. View Article : Google Scholar : PubMed/NCBI
23	Li W, Li Y, Zhu S, Ji Q, Shu Y, Zhang L and Liu J: Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44. Neurosci Lett. 584:314–319. 2015. View Article : Google Scholar : PubMed/NCBI
24	Jin SL and Conti M: Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses. Proc Natl Acad Sci USA. 99:7628–7633. 2002. View Article : Google Scholar : PubMed/NCBI
25	Jin SL, Lan L, Zoudilova M and Conti M: Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages. J Immunol. 175:1523–1531. 2005. View Article : Google Scholar : PubMed/NCBI
26	Robichaud A, Stamatiou PB, Jin SC, Lachance N, MacDonald D, Laliberté F, Liu S, Huang Z, Conti M and Chan CC: Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis. J Clin Invest. 110:1045–1052. 2002. View Article : Google Scholar : PubMed/NCBI
27	Bao F, Fleming JC, Golshani R, Pearse DD, Kasabov L, Brown A and Weaver LC: A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes and tissue damage after spinal cord injury. J Neurotrauma. 28:1035–1049. 2011. View Article : Google Scholar : PubMed/NCBI
28	Erdogan S, Aslantas O, Celik S and Atik E: The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection. Res Vet Sci. 84:18–25. 2008. View Article : Google Scholar : PubMed/NCBI
29	Pearse DD, Pereira FC, Marcillo AE, Bates ML, Berrocal YA, Filbin MT and Bunge MB: cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med. 10:610–616. 2004. View Article : Google Scholar : PubMed/NCBI
30	Nagasawa SY, Takuwa N, Sugimoto N, Mabuchi H and Takuwa Y: Inhibition of Rac activation as a mechanism for negative regulation of actin cytoskeletal reorganization and cell motility by cAMP. Biochem J. 385:737–744. 2005. View Article : Google Scholar : PubMed/NCBI
31	Sanz MJ, Cortijo J and Morcillo EJ: PDE4 inhibitors as new anti-inflammatory drugs: Effects on cell trafficking and cell adhesion molecules expression. Pharmacol Ther. 106:269–297. 2005. View Article : Google Scholar : PubMed/NCBI
32	Lorenowicz MJ, FernandezBorja M and Hordijk PL: cAMP signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol. 27:1014–1022. 2007. View Article : Google Scholar : PubMed/NCBI
33	Ninković J and Roy S: Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1- and p38 MAPK-dependent mechanisms. Am J Pathol. 180:1068–1079. 2012. View Article : Google Scholar : PubMed/NCBI
34	Emery AC and Eiden LE: Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor. FASEB J. 26:3199–3211. 2012. View Article : Google Scholar : PubMed/NCBI
35	Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Døskeland SO, Blank JL and Bos JL: A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol. 4:901–906. 2002. View Article : Google Scholar : PubMed/NCBI
36	Zhuang ZY, Gerner P, Woolf CJ and Ji RR: ERK is sequentially activated in neurons, microglia and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain. 114:149–159. 2005. View Article : Google Scholar : PubMed/NCBI